18th Dec 2006 14:03
GW Pharmaceuticals PLC18 December 2006 GW Pharmaceuticals PLC ("GW") In conformity with the Transparency Directive's transitional provision 6, GWhereby provides notification of the following information: GW's issued capital consists of 120,076,035 ordinary shares with voting rights.Therefore, the total number of voting rights in GW is 120,076,035. The above figure may be used by shareholders as the denominator for thecalculations by which they will determine if they are required to notify theirinterest in, or a change to their interest in, GW under the FSA's Disclosure andTransparency Rules. For further information, please contact: GW Pharmaceuticals PLC +44 (0)20 7831 3113Dr Geoffrey Guy, ChairmanJustin Gover, Managing Director This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
GWP.L